This dissertation discusses the surgical treatment of ovarian cancer after the disease has first been diagnosed and after it has returned following initial treatment. Predicting the outcome of surgical treatment should ideally take place within an experienced, multidisciplinary oncological team and should not be primarily based on prediction models consisting of clinical and CT scan parameters. If surgery is performed following a return of cervical cancer, the survival rate is higher compared to patients who are exclusively treated with chemotherapy. In the Netherlands, it has not been possible to use randomised testing to assess the value of surgery in recurrent ovarian cancer.
|Award date||2 Dec 2016|
|Place of Publication||Maastricht|
|Publication status||Published - 2016|
- ovarian cancer
- surgical treatment
- survival rate